Delivery Order SPE2DR25D9312-SPE2DR26FGEW3
Award Date 3/6/26
Potential Completion Date 3/27/26
Potential Value $16K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $11,648 delivery order to DMS Pharmaceutical Group Inc. on February 27, 2026, for Prolastin C 1,000 mg/20 ml vials under its Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract. PPV-G GEN V is a Defense Logistics Agency pharmaceutical supply contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 24, 2026, with a ceiling value of $17,888 for Prolastin C 1,000 mg/20 ml vials, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency program authorizing firm fixed-price delivery orders for pharmaceutical products, biologics, and medical consumables to support Department of Defense healthcare operations. Place of performance is...
- The Defense Logistics Agency issued a $10,200 delivery order to DMS Pharmaceutical Group Inc. on February 27, 2026, for Prolastin C 1,000 mg/20 ml under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is priced on a firm fixed-price basis with an ultimate completion date of March 20, 2026. Place of performance is Park Ridge, Illinois. The delivery order calls against the PPV-G GEN V indefinite...
- <p>The Defense Logistics Agency issued a $11,648 delivery order to DMS Pharmaceutical Group Inc. on March 6, 2026, for Prolastin C 1,000 mg/20 ml vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).</p> <p>DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL. The order carries a firm fixed price and an ultimate completion date of March 27, 2026. No set-aside was used.</p>
- The Defense Logistics Agency issued a $11,670.40 delivery order to DMS Pharmaceutical Group Inc. on February 10, 2026, for Prolastin C 1,000 mg/20 ml vials under the firm fixed-price Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, IL. The order has an ultimate completion date of March 4, 2026. No set-aside was applied to this delivery...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 18, 2026, for Prolastin C 1,000 mg/20 ml vials with a ceiling value of $23,848.80. The order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery contract with a $499.999 billion ceiling and performance period through December 31, 2036. DMS Pharmaceutical Group is a woman-owned small business...
- The Defense Logistics Agency awarded a delivery order valued at $15,063.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Prolastin C 1,000 mg/20 ml vials. The award, issued on January 15, 2026, with an ultimate completion date of February 6, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS...
- The Defense Logistics Agency awarded a $22,524.88 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. The delivery order, issued on January 13, 2026, with an ultimate completion date of February 4, 2026, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This award represents a single delivery...
- The Defense Logistics Agency awarded a $27,331.66 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. This firm fixed-price delivery order, issued on November 4, 2025, with an ultimate completion date of November 26, 2025, carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The award falls...
- The Defense Logistics Agency awarded a $36,160.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Prolastin C 1,000 mg/20 ml vials. The delivery order, issued on November 12, 2025, with an ultimate completion date of December 4, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award falls under DMS...
- SPE2DR25D9312Indefinite Delivery Contract
- SPE2DR25D9312-SPE2DR26FGEW3Delivery Order
The Defense Logistics Agency issued a $16,000 delivery order to DMS Pharmaceutical Group Inc. on March 6, 2026, for Prolastin C 1,000 mg/20 ml vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations worldwide. Place of performance is Park Ridge, IL. Ultimate completion date for this order is March 27, 2026. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler.
Generated 6/4/26, 11:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.0k | 3/5/26 |